Heel medicines are available in 50 countries worldwide. Choose your country below to learn more.
Hans-Heinrich Reckeweg Clinical Case Award 2017 - Submission closedBiologische Heilmittel Heel GmbH supports the acknowledgement of clinical case reporting in the form of the annual Hans-Heinrich Reckeweg Clinical Case Award. The Award is bestowed on the premises of the International Award Committee for excellent reporting in accordance with the CARE guidelines (care-statement.org), ensuring transparency and accuracy of health research reporting. The submission is now closed. More on the Hans-Heinrich Reckeweg Clinical Case Award
Heel receives Top Employer award for the eighth time in successionOnce again in 2017, Biologische Heilmittel Heel GmbH is one of the best employers in Germany. From among 114 companies evaluated nationwide, the manufacturer of natural medicines has been certified as ‘Top Employer Germany’ by the independent Top Employers Institute for the eighth time in succession. More on Heel as Top Employer
Press releaseHeel’s Traumeel® and Zeel® T shown to reduce pain of OA of the knee by more than 60% in MOZArT trial - Clinical data released at the 2015 European League Against Rheumatism (EULAR) congress show Traumeel® and Zeel® T co-administered intra-articular (IA) injections provide a new first line injection treatment option in the management of moderate to severe osteoarthritis of the knee, where oral pain management failed. More press releases